TLR4 and Insulin resistance: This process leads to impaired gut barrier integrity and release of LPS from intestinal gram-negative bacteria into the bloodstream [14, 22] which in turn leads to Toll-like receptor 4 (TLR4)-mediated metabolic endotoxemia (ME), LGCI and insulin resistance in obese mice [23, 24].